Michael David Smith

Board Director

Director

US·SEC (Form 4)

Proterra IncKalVista Pharmaceuticals, Inc.

Cumul. flow

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 13 Mar 2024 for Proterra Inc. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Michael David Smith: trading record in brief

Michael David Smith is a declared insider at 2 companies (board member); the most frequent names are Proterra Inc and KalVista Pharmaceuticals, Inc. Between 1 June 2021 and 13 March 2024, the trades on record add up to 7 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The record was last updated on 13 March 2024 with a transaction in Proterra Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.